Down-regulation of CXCR4 expression in MT4 cells by a recombinant vector expressing antisense RNA to CXCR4 and its potential anti-HIV-1 effect

Japanese Journal of Infectious Diseases

Volumn 57, Issue 3, 2004, Pages 91-96

  Xing, Hui Chun ^b,d   Xu, Xiao Yuan ^d   Liu, Zhen ^c,d   Wang, Qin Huan ^a,d   Yu, Min ^d   Si, Chong Wen ^d  

^a Zhejiang University ^*  (China)

^b ZHEJIANG UNIVERSITY   (China)

^c National Center for AIDS   (China)

^d PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; COMPLEMENTARY RNA; DNA FRAGMENT; MESSENGER RNA; RETROVIRUS VECTOR; VIRUS DNA; GAG PROTEIN;

ANIMAL CELL; ARTICLE; CELL LINE; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; DNA SYNTHESIS; DOWN REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSLATION; T LYMPHOCYTE; VIRION; VIRUS DNA CELL DNA INTERACTION; VIRUS RECOMBINANT; VIRUS TRANSMISSION; BIOSYNTHESIS; DRUG ANTAGONISM; DRUG EFFECT; FLOW CYTOMETRY; GENE VECTOR; GENETICS; METABOLISM;

CELL LINE, TRANSFORMED; DOWN-REGULATION; FLOW CYTOMETRY; GENETIC VECTORS; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; RECEPTORS, CXCR4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, ANTISENSE; TRANSFECTION;

EID: 4143136596     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Stefano, V. and Palmisano, L. (2000): Antiretroviral therapy: state of the HAART. Antiviral Res., 45, 1-7.
2. Tanuri, A., Caridea, E., Dantas, M. C., Morgado, M. G., Mello, D. L. C., Borges, S., Tavares, M., Ferreira, S. B., Santoro-Lopes, G., Martins, C. R. F., Esteves, A. L. C., Diaz, R. S., Andreo, S. M. S., Ferreira, L. A. P., Rodrigues, R., Reuter, T., Cavalcanti, A. M. S., Oliveira, S. M., Barbosa, H. B., Teixeira, P. R. and Chequer, P. N. (2002): Prevalence of mutations related to HIV-1 antiretroviral resistance in Brazilian patients failing HAART. J. Clin. Virol., 25, 39-46.
3. Wegner, S. A., Brodine, S. K., Mascola, J. R., Tasker, S. A., Shaffer, R. A., Starkey, M. J., Barile, A., Martin, G. J., Aronson, N., Emmons, W. W., Stephan, K., Bloor, S., Vingerhoets, J., Hertogs, K. and Larder, B. (2000): Prevalence of genotypic and phenotypic resistance to antiretroviral, drugs in a cohort of therapy-naïve HIV-1 infected US military personnel. AIDS, 14, 1009-1015.
4. Feng, Y., Broder, C. C., Kennedy, P. E. and Berger, E. A., (1996): HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science, 272, 872-877.
5. Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Di Marzio, P., Marmon, S., Sutton, R. E., Hill, C. M., Davis, C. B., Peiper, S. C., Schall, T. J., Littman, D. R. and Landau, N. R. (1996): Identification of a major co-receptor for primary isolates of HIV-1. Nature, 381, 661-666.
6. Horuk, R. (2001): Chemokine receptors. Cytokine Growth Factor Rev., 12, 313-335.
7. Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Smith, M. W., Allikmets, R., Goedert, J. J., Buchbinder, S. P., Vittinghoff, E., Gomperts, E., Donfield, S., Vlahov, D., Kaslow, R., Saah, A., Rinaldo, C., Detels, R. and O'Brien, S. J. (1996): Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science, 273, 1856-1862.
8. Liu, R., Paxton, W. A., Choe, S., Ceradini, D., Martin, S. R., Horuk, R., MacDonald, M. E., Stuhlmann, H., Koup, R. A. and Landau, N. R. (1996): Homozygous defect in HIV-1 coreceptor accounts for resistance some multiply exposed individuals to HIV-1 infection. Cell, 86, 367-377.
9. 5 chemokine receptor gene. Nature, 382, 722-725.
10. 5 genotype and the clinical course of HIV-1 infection. Ann. Intern. Med., 127, 882-890.
11. Bai, X., Chen, J. D., Yang, A. G., Torti, F. and Chen, S. Y. (1998): Genetic co-inactivarion of macrophage- and T-tropic HIV-1 chemokine coreceptors CCR-5 and CXCR-4 by intrakines. Gene Ther., 5, 984-994.
12. Magiorkinis, E., Paraskevis, D., Magiorkinis, G., Chryssou, S., Chini, M., Lazanas, M., Paparizos, V., Saroglou, G., Antoniadou, A., Giamarellou, E., Karafoulidou, A. and Hatzakis, A. (2002): Mutations associated with genotypic resistance to antiretroviral therapy in treatment naïve HIV-1 infected patients in Greece. Virus Res., 85, 109-115.
13. Tanuri, A., Caridea, E., Dantas, M. C., Morgado, M. G., Mello, D. L., Borges, S., Tavares, M., Ferreira, S. B., Santoro-Lopes, G., Martins, C. R., Esteves, A. L., Diaz, R. S., Andreo, S. M., Ferreira, L. A., Rodrigues, R., Reuter, T., Cavalcanti, A. M., de Oliveira, S. M., de Barbosa, H. B., Teixeira, P. R. and Chequer, P. N. (2002): Prevalence of mutations related to HIV-1 antiretroviral resistance in Brazilian patients failing HAART. J. Clin. Virol., 25, 39-46.
14. Rosenzweig, M., Marks, D. F., Hempel, D., Lisziewicz, J. and Johnson, R. P. (1997): Transduction of CD34+ hematopoietic progenitor cells with an antitat gene protects T-cell and macrophage progeny from AIDS virus infection. J. Virol., 71, 2740-2746.
15. Browning, C. M., Cagnon, L., Good, P. D., Rossi, J., Engelke, D. R. and Markovitz, D. M. (1999): Potent inhibition of human immunodeficiency virus type 1 (HIV-1) gene expression and virus production by an HIV-2 Tat activation-response RNA decoy. J. Virol., 73, 5191-5195.
16. Inouye, R. T., Du, B., Boldt-Houle, D., Ferrante, A., Park, I. W., Hammer, S. M., Duan, L., Groopman, J. E., Pomerantz, R. J. and Terwilliger, E. F. (1997): Potent inhibition of human immunodeficiency virus type 1 in primary T cells and alveolar macrophages by a combination anti-Rev strategy delivered in an adeno-associated virus vector. J. Virol., 71, 4071-4078.
17. Morel, F., Salimi, S., Markovits, J., Austin, T. W. and Plavec, I. (1999): Hematologic recovery in mice transplanted with bone marrow stem cells expressing antihuman immunodeficiency virus genes. Hum. Gene Ther., 10, 2779-2787.
18. Ranga, U., Woffendin, C., Verma, S., Xu, L., June, C. H., Bishop, D. K. and Nabel, G. J. (1998): Enhanced T cell engraftment after retroviral delivery of an antiviral gene in HIV-infected individuals. Proc. Natl. Acad. Sci. USA, 95, 1201-1206.
19. Brower, V., Chahine, K., Dorey, E., Dove, A., Francisco, M., Hodgson, J., Michael, A. and Marshall, A. (1998): All clear for HIV-targeting ribozyme in phase II. Nat. Biotechnol, 16, 123-123.
20. Yang, O. O., Swanberg, S. L., Lu, Z., Dziejman, M., McCoy, J., Luster, A. D., Walker, B. D. and Herrmann, S. H. (1999): Enhanced inhibition of human immunodeficiency virus type 1 by Met-stromal-derived factor 1 β correlates with down-modulation of CXCR4. J. Virol., 73, 4582-4589.